Qiuchen Chen

965 total citations
17 papers, 694 citations indexed

About

Qiuchen Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qiuchen Chen has authored 17 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Qiuchen Chen's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (5 papers). Qiuchen Chen is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (5 papers). Qiuchen Chen collaborates with scholars based in China, Saint Kitts and Nevis and United States. Qiuchen Chen's co-authors include Minjie Wei, Huizhe Wu, Xiao Hu, Yalun Li, Weifan Yao, Tong Sun, Senxu Lu, Miao He, Wenyan Qin and Haishan Zhao and has published in prestigious journals such as Oncogene, Scientific Reports and Molecular Cancer.

In The Last Decade

Qiuchen Chen

17 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiuchen Chen China 13 606 443 96 49 30 17 694
Mujie Ye China 16 400 0.7× 257 0.6× 81 0.8× 39 0.8× 24 0.8× 38 510
Chunlong Yang China 11 616 1.0× 313 0.7× 80 0.8× 53 1.1× 45 1.5× 16 672
Jiwei Guo China 11 507 0.8× 297 0.7× 50 0.5× 44 0.9× 23 0.8× 21 615
Juhong Wang China 12 419 0.7× 280 0.6× 83 0.9× 50 1.0× 26 0.9× 17 507
Yuejie Lu China 9 545 0.9× 428 1.0× 71 0.7× 104 2.1× 38 1.3× 15 678
Yuxiang Qiu China 11 344 0.6× 247 0.6× 82 0.9× 38 0.8× 18 0.6× 17 482
Dejun Wu China 12 323 0.5× 213 0.5× 98 1.0× 90 1.8× 22 0.7× 19 467
Nils Degrauwe Switzerland 5 342 0.6× 198 0.4× 59 0.6× 24 0.5× 19 0.6× 7 431
Kaifang Ma China 11 432 0.7× 323 0.7× 87 0.9× 150 3.1× 44 1.5× 28 614

Countries citing papers authored by Qiuchen Chen

Since Specialization
Citations

This map shows the geographic impact of Qiuchen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuchen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuchen Chen more than expected).

Fields of papers citing papers by Qiuchen Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuchen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuchen Chen. The network helps show where Qiuchen Chen may publish in the future.

Co-authorship network of co-authors of Qiuchen Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuchen Chen. A scholar is included among the top collaborators of Qiuchen Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuchen Chen. Qiuchen Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wu, Ting, Ying‐Qi Zhao, Xinming Zhang, et al.. (2025). Short‐chain acyl post‐translational modifications in cancers: Mechanisms, roles, and therapeutic implications. Cancer Communications. 45(10). 1247–1284. 17 indexed citations
2.
Fu, Chen, et al.. (2024). Characterization and efficacy of C60 nano-photosensitive drugs in colorectal cancer treatment. Biomedicine & Pharmacotherapy. 176. 116828–116828. 9 indexed citations
3.
Wu, Huizhe, Xiangyu Ding, Xiao Hu, et al.. (2022). LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer. Oncogene. 41(13). 1959–1973. 20 indexed citations
4.
Hu, Xiao, Qiuchen Chen, Hao Guo, et al.. (2021). Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis. Frontiers in Oncology. 11. 657984–657984. 8 indexed citations
5.
Lu, Senxu, Li Han, Xiao Hu, et al.. (2021). N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer. Journal of Hematology & Oncology. 14(1). 188–188. 88 indexed citations
6.
Wang, Xiufang, Zhikun Wu, Wenyan Qin, et al.. (2020). Long non-coding RNA ZFAS1 promotes colorectal cancer tumorigenesis and development through DDX21-POLR1B regulatory axis. Aging. 12(22). 22656–22687. 26 indexed citations
7.
Sun, Tong, Zhikun Wu, Xiufang Wang, et al.. (2020). LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression. Oncogene. 39(31). 5358–5372. 154 indexed citations
8.
Wu, Huizhe, Xiao Hu, Yalun Li, et al.. (2020). LNC473 Regulating APAF1 IRES-Dependent Translation via Competitive Sponging miR574 and miR15b: Implications in Colorectal Cancer. Molecular Therapy — Nucleic Acids. 21. 764–779. 5 indexed citations
9.
Wu, Huizhe, Wenyan Qin, Senxu Lu, et al.. (2020). Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2′-O-methylation via NOP58 recruitment in colorectal cancer. Molecular Cancer. 19(1). 95–95. 100 indexed citations
10.
Xu, Dong-ping, Yutong Wu, Xiufang Wang, et al.. (2020). Identification of functional circRNA/miRNA/mRNA regulatory network for exploring prospective therapy strategy of colorectal cancer. Journal of Cellular Biochemistry. 121(12). 4785–4797. 30 indexed citations
11.
Chen, Qiuchen, Xiaolan Deng, Xiao Hu, et al.. (2019). Breast Cancer Risk–Associated SNPs in the mTOR Promoter Form De Novo KLF5- and ZEB1-Binding Sites that Influence the Cellular Response to Paclitaxel. Molecular Cancer Research. 17(11). 2244–2256. 10 indexed citations
12.
Qin, Wenyan, Xiaodong Wang, Yilin Wang, et al.. (2019). Functional polymorphisms of the lncRNA H19 promoter region contribute to the cancer risk and clinical outcomes in advanced colorectal cancer. Cancer Cell International. 19(1). 215–215. 13 indexed citations
13.
Zhang, Zhen, Qiuchen Chen, Jing Zhang, et al.. (2017). Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population. Scientific Reports. 7(1). 17844–17844. 16 indexed citations
14.
Wu, Huizhe, Hui Wang, Shu Guan, et al.. (2017). Cell-specific regulation of proliferation by Ano1/TMEM16A in breast cancer with different ER, PR, and HER2 status. Oncotarget. 8(49). 84996–85013. 27 indexed citations
15.
Zhao, Haishan, Zhaojin Yu, Lin Zhao, et al.. (2016). HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy. Japanese Journal of Clinical Oncology. 46(10). 893–902. 36 indexed citations
16.
Ma, Mengtao, Miao He, Qian Jiang, et al.. (2016). MiR-487a Promotes TGF-β1-induced EMT, the Migration and Invasion of Breast Cancer Cells by Directly Targeting MAGI2. International Journal of Biological Sciences. 12(4). 397–408. 47 indexed citations
17.
Zhao, Lin, Mengtao Ma, Xuefeng Bai, et al.. (2013). MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). Breast Cancer Research and Treatment. 139(3). 717–730. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026